GH research stack

What GH research stack is

GH research stack holds CJC-1295 (no DAC) and Ipamorelin as separate vials, together with the supplies needed to work with them. They are sold together because their published research sits in overlapping areas, not because any study has tested them as a combination. Each vial is reconstituted and used independently.

The compounds in this stack

CJC-1295 (no DAC)

CJC-1295 (no DAC) is growth hormone-releasing hormone (GHRH) analogue. Its published work is in rat and human. On the evidence, 1 of its 6 cited studies is a controlled trial in people.

6 cited studies on the CJC-1295 (no DAC) page, each with the model it used.

Ipamorelin

Ipamorelin is growth hormone secretagogue (ghrelin receptor agonist). Its published work is in rat, human and primary rat pituitary cells. On the evidence, 1 of its 8 cited studies is a controlled trial in people.

8 cited studies on the Ipamorelin page, each with the model it used.

What the research does not show

Status in Canada

Neither CJC-1295 (no DAC) nor Ipamorelin holds a Drug Identification Number in Canada, which means Health Canada has not assessed them for safety, efficacy or quality. Supplied for in-vitro laboratory research only.

Each vial arrives as a lyophilised powder, sealed, with the HPLC certificate for its own batch. The batch number is printed on the vial, so a result can be traced back to the material that produced it. Bacteriostatic water is included where the bundle lists it; nasal sprays and capsules, if any, arrive ready to use.

What's in the kit